Article
Efficacy and safety of tofacitinib in treatment of pemphigus: a single-center cohort study
2025-03-11
Abstract excerpt
<title>Abstract</title> <p>To evaluate the efficacy, safety, and steroid-sparing effect of tofacitinib combined with corticosteroids (CS) in pemphigus treatment. Clinical data from moderate pemphigus patients treated with CS monotherapy or CS plus tofacitinib (CT) between June 2019 and January 2024 were analyzed. The primary endpoint was complete remission (CR) rate at 1 year. Secondary endpoints comprised the mo...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b69d269f-934d-5f2c-9eab-d436a3a5d915
- DOI
- 10.21203/rs.3.rs-6138704/v1
